The general objective of the project is to provide medical services for prevention, early detection (screening), diagnosis and treatment of patients with chronic liver diseases secondary to viral infections with hepatitis B/D and C viruses in the development regions South Muntenia and South-West Oltenia, respectively in Arges County (AG), Calarasi (CL), Dambovita (DB), Giurgiu (GR), Ialomita (IL), Prahova (PH), Teleorman (TR), Dolj (DJ), Gorj (GJ), Mehedinti (MH), Olt (OT) and Valcea (VL). This general objective responds to a theme of national interest in the field of health, namely: Reducing the incidence of priority communicable diseases: hepatitis B and C and providing patients with access to antiviral treatments (Objective 2.5 of the National Health Strategy 2014-2020) that indicate concrete measures to be followed in the directions: Increasing the role and capacity of first-line health service providers for prevention, early diagnosis and treatment of liver B virus infections, according to specific competences; Minimising occupational biological risk in healthcare and social care personnel; Increased knowledge of the epidemiological profile of HVB and HVC infection in the general population or in certain population groups through prevalence studies, epidemiological research, development of the national registry of HVB/HVC-infected patients. The added value (VA) expressed by the positive socio-economic effects of the project implementation can be quantified on the following directions: (VA1) benefits for the target group in the regions of South Muntenia and South-West Oltenia: participation in free testing/screening for viral hepatitis; information on the risks of self-infection and dissemination of the infection to other persons; information and awareness of the major negative effects on life of the person chronically infected with hepatitis B/D or C; ensuring accurate diagnosis through staging, free of charge for positive patients detected during rapid testing; (VA2) additional benefits for vulnerable groups South Muntenia and South-West Oltenia: free access to rapid diagnosis (screening) and diagnosis of staging; providing accompanying services to and from prevention centers; guidance to the legal means of insurance of uninsured persons in order to benefit from the treatment settled by the CNAS. (VA3) impact on the target group in the regions of South Muntenia and South-West Oltenia: ensuring the prerequisites for a healthy life and reducing the risks of disseminating communicable diseases in society; (VA4) impact on vulnerable groups South Muntenia and South-West Oltenia: equal treatment with non-vulnerable people, providing the premises for obtaining treatment and eradicating the hepatitis C profile among the most vulnerable populations
